EYPT - Company ID 0001314102
As of 2026-10-19, EyePoint Pharmaceuticals, Inc. (EYPT) has a market capitalization of $250.69 M, making it the #2672 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-10-19 | $250.69 M |
| 2026-10-18 | $250.69 M |
| 2026-10-17 | $250.69 M |
| 2026-10-16 | $250.69 M |
| 2026-10-15 | $264.52 M |
| 2026-10-14 | $252.36 M |
| 2026-10-13 | $257.39 M |
| 2026-10-12 | $278.35 M |
| 2026-10-11 | $285.06 M |
| 2026-10-10 | $285.06 M |
| 2026-10-09 | $285.06 M |
| 2026-10-08 | $290.09 M |
As of 2026-10-19, EyePoint Pharmaceuticals, Inc. (EYPT) has a market capitalization of $250.69 M, making it the #2672 most valuable US-listed company.
EyePoint Pharmaceuticals, Inc. is the #2672 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-07 | $279.61 M |
| 2026-10-06 | $265.78 M |
| 2026-10-05 | $262.84 M |
| 2026-10-04 | $272.48 M |
| 2026-10-03 | $272.48 M |
| 2026-10-02 | $272.48 M |
| 2026-10-01 | $270.81 M |
| 2026-09-30 | $279.19 M |
| 2026-09-29 | $286.74 M |
| 2026-09-28 | $277.93 M |
| 2026-09-27 | $303.51 M |
| 2026-09-26 | $303.51 M |
| 2026-09-25 | $303.51 M |
| 2026-09-24 | $306.02 M |
| 2026-09-23 | $314.40 M |
| 2026-09-22 | $341.23 M |
| 2026-09-21 | $337.04 M |
| 2026-09-20 | $322.79 M |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.